
AgeRate
Utilizing predictive algorithms with multi-omic datasets to derive meaningful insights into your health and longevity. With a blood test we allow people to monitor their agerate and discover how they can alter their lifestyle habits to slow or reverse aging.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | $30.0k | Grant | |
Total Funding | 000k |
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 50 % | - | - |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
AgeRate is a direct-to-consumer longevity and health-tech company operating in the wellness market. The Canadian-based firm, founded in 2018, provides health-conscious consumers with tools to monitor and understand their biological aging process. The company's origins trace back to McMaster University, where co-founder and CEO Cole Kirschner and co-founder Nathan Cawte were conducting research. Kirschner, who holds a degree in Biotechnology with a minor in Business Management from McMaster, leveraged his passion for health optimization and prior experience at a genetic testing startup to establish AgeRate. The founding team also includes Dr. Guillaume Paré as Chief Scientific Officer, a respected authority in cardiovascular genetics who was a professor at McMaster.
The company's core offering is a direct-to-consumer service that combines an at-home blood test with a companion mobile application. This service analyzes a user's DNA methylation patterns using proprietary algorithms to determine their biological age, offering a different perspective than chronological age. The epigenetic analysis measures over 50,000 markers to provide its insights. Beyond a single biological age number, the platform delivers up to 20 additional health and longevity reports on key areas such as metabolic health, inflammation, immune health, and cognitive function. The blood collection process is designed to be painless, and samples are processed in CLIA-certified labs to ensure high standards.
The business model is primarily subscription-based, centered on selling test kits directly to consumers. Customers purchase a kit, collect a blood sample at home, mail it to the lab, and receive their detailed reports and personalized, science-backed recommendations through the AgeRate mobile app. The app serves as a longevity partner, helping users build healthy habits and track their progress over time by re-testing periodically. AgeRate also has plans to expand its market channels by offering its services to clinicians and partnering with companies, such as supplement providers, to help them validate the effectiveness of their anti-aging products.
Keywords: biological age testing, epigenetic analysis, longevity, health-tech, direct-to-consumer health, preventative health, at-home blood test, DNA methylation, health optimization, personalized wellness, cellular health, anti-aging, healthspan, mobile health app, wellness monitoring, Cole Kirschner, McMaster University, consumer diagnostics, lifestyle recommendations, proactive health